好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Does the Truth Lie Within the Gut? Investigating the Gut Microbiome in an Australian Cohort of Parkinson’s Disease Patients
Movement Disorders
S17 - Parkinson's Disease Biomarkers and Pathophysiology (2:00 PM-2:12 PM)
006
To date, there remains a limited number of studies that have reported an association between altered microbiota composition, GI symptoms, and PD, and it remains to be seen if this association exists within an Australian cohort.

Despite being recognised primarily as a motor disorder, gastrointestinal (GI) dysfunction is one of the first symptoms reported by individuals with Parkinson’s disease (PD). This is hypothesised to result from a change in microbiota towards an inflammatory, dysbiotic composition.

This study involved a multi-centre assessment of 167PD patients and 100 healthy-controls from St Vincent’s Movement Disorders Clinic (Fitzroy, VIC), the Perron Institute Movement Disorders Clinic (Nedlands, WA). The Gastrointestinal Symptom Rating Scale (GSRS) was employed to measure the frequency and severity of GI-associated symptoms. Clinical and demographic measures, and the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) were undertaken on PD patients. Stool samples were analyzed using targeted sequencing of the V3-V4 regions of 16s rRNA genes.

Results indicate that PD patients have significantly worse GI symptoms (e.g. acid reflux, decreased passage of stools and nausea/vomiting (p < 0.05)), when compared to healthy controls. Subsequently, the study identified that both relative abundance and diversity of microbial phyla/genera were significantly different in patients with PD when compared to healthy controls (p<0.05). Specifically, Firmicutes, Proteobacteria and Verrucomicrobia were all increased within PD. Reduced microbial diversity was significantly associated with greater disease and GI symptom severity.

Consequently, this suggests that worse GI symptom presentation and severity in PD patients could be due to an altered microbiome composition and reduced diversity. Furthermore, as GI symptoms are one of the first to present, these results provide evidence for the use of the GSRS assessment to identify early symptoms in PD patients, and further explores the gut-brain connection in the progression and management of this disease.
Authors/Disclosures
Jade E. Kenna (The Perron Institute)
PRESENTER
No disclosure on file